IshwariaSubbiahMDMS

Oncology • Nashville, TN

Hospice & Palliative, Complementary and Integrative

Executive Director, Cancer Care Equity and Professional Wellness

Join to view full profile

Dr. Subbiah is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Subbiah's full profile

Already have an account?

Office
1100 Dr. Martin L. King, Jr. Blvd
Suite 800
Nashville, TN 37203

Summary

I am a medical oncologist and a palliative care & integrative medicine physician. I joined Sarah Cannon Research Institute (SCRI) as the Executive Director, Cancer Care Equity and Professional Wellness. In this role, I focus on key overarching areas of our mission: (1) to reduce cancer outcomes disparities and diversify clinical trial participation within SCRI’s combined research network of over more than 1,300 physicians at over 250 locations in 24 states across the US providing care for about 1.4 million people with cancer, and (2) build the organization’s healthcare professional well-being program to support multidisciplinary oncology research professionals in the community.

Prior to joining SCRI in 2023, I spent nearly 12 years at the University of Texas MD Anderson Cancer Center, most recently as an Associate Professor in the Division of Cancer Medicine. After my residency in Internal Medicine, I completed clinical fellowships in Developmental Therapeutics, Medical Oncology, and Palliative Medicine, all at MD Anderson, before joining the faculty there.

With this expertise in geriatric oncology, symptom management, palliative care, and healthcare professional well-being, I have over a decade of experience leading teams in developing and implementing organization-wide programs to improve cancer care and clinical workplace experience, including leading their integration of patient reported outcomes-based remote symptom monitoring.

Education & Training

Rice UniversityCertificate, Health Care Management, 2018
University of Texas M D Anderson Cancer CenterFellowship, Hospice and Palliative Medicine, 2015 - 2016
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
University of Texas M D Anderson Cancer CenterFellowship, Investigational Cancer Therapeutics Fellowship In Early Drug Development, 2011 - 2012
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2009 - 2011
Albany Medical CenterInternship, Internal Medicine, 2008 - 2009
St. George's University School of MedicineClass of 2008
Johns Hopkins UniversityMS, Biotechnology, 2005
Johns Hopkins UniversityBS, Molecular and Cellular Biology, 2004

Certifications & Licensure

FL State Medical License 2021 - Present
TN State Medical License 2023 - 2026
TX State Medical License 2016 - 2025
OK State Medical License 2020 - 2021
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hospice and Palliative Medicine

Awards, Honors, & Recognition

Young Investigator Award Finalist The International Society of Geriatric Oncology (SIOG), 2017
AACR-GlaxoSmithKline Outstanding Clinical Scholar Award American Association for Cancer Research, 2013
Conquer Cancer Foundation Merit Award American Society of Clinical Oncology, 2013
Extramural Award for Patient-oriented Research Loan Repayment Program National Institutes of Health (NIH), 2013
AACR-Warner Fund Scholar-in-Training Award American Association for Cancer Research, 2012
ASCO/AACR Methods in Clinical Trials Workshop American Society of Clinical Oncology/American Association for Cancer Research, 2012
Finalist, Bristol-Myers Squibb Award, Postgraduate Clinical/Translational Research MD Anderson Alumni and Faculty Association, 2012
Trainee Excellence Award MD Anderson Alumni and Faculty Association, 2012
American College of Gastroenterology Presidential Poster Award American College of Gastroenterology, 2010
Merit/Travel Award winner for the American Society of Hematology (ASH)/Hemophilia and Thrombosis Research Society (HTRS) Coagulation Disorders Workshop American Society of Hematology (ASH)/Hemophilia and Thrombosis Research Society (HTRS), 2010
Beta Beta Beta Honor Society Johns Hopkins University, 2003
Office of Student Involvement Leadership Award Johns Hopkins University, 2003
The Chester Wickwire Diversity Award Johns Hopkins University, 2003
Dean's List Johns Hopkins University, 2002-2003
Intramural Research Training Award National Institutes of Health, 2000
Join now to see all

Publications & Presentations

PubMed

State of Geographic Access to Cancer Treatment Trials in the United States: Are Studies Located Where Patients Live?
M Kelsey Kirkwood, Caroline Schenkel, Dominique C Hinshaw, Suanna S Bruinooge, David M Waterhouse
JCO Oncology Practice. 2024-10-02
3 citations
Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline.
Ilana M Braun, Kari Bohlke, Donald I Abrams, Holly Anderson, Lynda G Balneaves
Journal of Clinical Oncology. 2024-05-01
1 citations
A Vision for Democratizing Next-Generation Oncology Clinical Trials.
Vivek Subbiah, Denis Horgan, Ishwaria M Subbiah
Cancer Discovery. 2024-04-04

Journal Articles

Development of a prognostic scoring system for patients with advanced cancer enrolled in immune checkpoint inhibitor phase 1 clinical trials
Sen S, Hess K, Hong DS, Naing A, Piha-Paul S, Janku F, Fu S, Subbiah IM, Liu H, Khanji R, Huang L, Moorthy S, Karp DD, Tsimberidou A, Meric-Bernstam F, Subbiah V, Br J Cancer, 1/1/2018
Outcomes of patients 65 years old with advanced cancer treated on phase I trials at MD Anderson Cancer Center
Subbiah IM, Wheler JJ, Hess KR, Hong DS, Naing A, Fu S, Kurzrock R, Tsimberidou AM, Int J Cancer, 1/1/2017
Palliative Care in the Time of Hurricane Harvey
Subbiah IM, Pallimed, 1/1/2017
STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid f...
Subbiah V, McMahon C, Patel S, Zinner R, Silva EG, Elvin JA, Subbiah IM, Ohaji C, Ganeshan DM, Anand D, Levenback CF, Berry J, Brennan T, Chmielecki J, Chalmers ZR, Ma..., J Hematol Oncol, 1/1/2015
Targeted therapy of advanced gallbladder cancer and cholangiocarcinoma with aggressive biology: eliciting early response signals from phase 1 trials
Subbiah IM, Subbiah V, Tsimberidou AM, Naing A, Kaseb AO, Javle M, Fu S, Hong DS, Piha-Paul S, Wheler JJ, Hess KR, Janku F, Falchook GS, Wolff RA, Kurzrock R, Oncotarget, 1/1/2013
Cardiovascular toxicity profiles of vascular-disrupting agents
Subbiah IM, Lenihan DJ, Tsimberidou AM, Oncologist, 1/1/2011
Join now to see all

Books/Book Chapters

Manual of Medical Oncology
Chapter: Chapter 21: Colorectal Cancer.
Morris V, Subbiah IM, Kopetz S, Eng CMcGraw Hill Professional, New York, NY2016
Comprehensive Rectal Cancer Care
Chapter: The Management of Metastatic Disease.
Subbiah IM, Eng C, Lou EPertinax Publishing, United Kingdom2015

Abstracts/Posters

Caring for the caregiver during the cancer journey.
Subbiah IM, The Cholangiocarcinoma Foundation Annual Meeting, Salt Lake City, UT, 1/30/2019
Holistic care from the hospital's front door: pain management and symptom control in the Emergency Center.
Subbiah IM, Oncologic Emergency Medicine Annual Conference, Houston, TX, 1/18/2019
Characteristics and Incidence of Immune-Related Toxicities Among Older Adults on Immunotherapy-Based Phase I Trials.
Subbiah IM, Multinational Association of Supportive Care in Cancer (MASCC) 2018 Annual Meeting, Vienna, Austria, 1/29/2018
A Comparative Analysis of Participation And Clinical Benefit Among Older Adults Versus Middle Age and AYA Patients on Phase I Clinical Trials with VEGF/VEGFR Inhibitors.
Subbiah IM, Multinational Association of Supportive Care in Cancer (MASCC) 2018 Annual Meeting, Vienna, Austria, 1/29/2018
What's New in Palliative & Supportive Care: 5 Most Impactful Publications this Year.
Subbiah IM, 22nd Annual Interdisciplinary Conference on Supportive Care, Hospice and Palliative Medicine, Houston, TX, 1/15/2018
PROs & Patient Experience: The Role of Patient-Reported Outcomes in Patient-Centered, Value-Driven Care
Subbiah IM, 22nd Annual Interdisciplinary Conference on Supportive Care, Hospice and Palliative Medicine, Houston, TX, 1/15/2018
Supportive Care & the Survivor: Exploring the intersection of Palliative Care and Cancer Survivorship.
Subbiah IM, University of Texas MD Anderson Cancer Center, 30th Annual myCancerConnection Cancer Survivorship Conference, Houston, TX, 1/14/2018
Caring for the spirit of persons with advanced illness during crisis: The Harvey Experience.
Subbiah IM, Seventh Annual Symposium of the Institute for Spirituality and Health: The Collective Soul, Houston, TX, 1/10/2018
A Comparative Analysis of Participation And Clinical Benefit Among Older Adults Versus Middle Age and AYA Patients on Phase I Clinical Trials with VEGF/VEGFR Inhibitors.
Subbiah IM, MASCC/ISOO Annual Meeting on Supportive Care in Cancer, 1/1/2018
Too old for treatment? Care for senior adults with a new diagnosis of cancer.
Subbiah IM, 21st Annual Interdisciplinary Conference on Supportive Care, Hospice and Palliative Medicine, Houston, TX, 1/14/2017
Immuno-oncology and the Older Adult: Comprehensive analysis of immune-related toxicities among older adults treated on novel immunotherapy-based phase I clinical trials.
Subbiah IM, Annual Conference of the International Society of Geriatric Oncology (SIOG), Warsaw, Poland, 1/10/2017
Integration of supportive care in immuno-oncology trials: Investigating the incidence and severity of immune-related toxicities among older adults versus mid-age patie...
Subbiah IM, Hess KR, Fujii R, Lui A, Subbiah V, Naing A, Hong DS, ASCO Palliative and Supportive Care in Oncology Symposium, 1/1/2017
Call to integrate supportive care and patient reported outcomes in early phase clinical trials: An exploration of adolescent and young adult (AYA) participation on pha...
Subbiah IM, Tang C, Rao A, Subbiah V, Kurzrock R, Hong DS, ASCO Palliative and Supportive Care in Oncology Symposium, 1/1/2017
Immuno-oncology and the elderly: A comparative analysis of participation and toxicities of senior adults aged 65 years and above vs mid age and adolescent/young adult ...
Subbiah IM, Hess KR, Fujii T, Alshawa A, Lui A, Roy S, Khanji R, Subbiah V, Naing A, Hong DS, J Clin Oncol, 1/1/2017
Clinical benefit rate and participation of patients with advanced cancer on phase I clinical trials: A comparative analysis of senior adults aged 65 years and above ve...
Subbiah IM, Tang C, Rao A, Falchook GS, Subbiah V, Kurzrock R, Karp D, Hong DS, 2016 Annual Conference of the International Society of Geriatric Oncology (SIOG), Milan, Italy, 1/18/2016
Transforming Lives of Patients with Advanced Illness and Caregivers in Suffering - Invocation.
Subbiah IM, Sixth Annual Symposium of the Institute for Spirituality and Health: The Collective Soul, Houston, TX, 1/13/2016
Clinical benefit rate and participation of patients with advanced cancer on phase I clinical trials: A comparative analysis of senior adults aged 65 years and above ve...
Subbiah IM, Tang C, Rao A, Subbiah V, Kurzrock R, Karp D, Hong DS, J Geriatr Oncol., 1/1/2016
Significant systemic and CNS activity of RET inhibitor vandetanib combined with mTOR inhibitor everolimus in patients with advanced NSCLC with RET fusion.
Cascone T, Subbiah V, Hess KR, Nelson S, Nilsson MB, Subbiah IM, Ali SM, Carbone DP, Salgia R, Owonikoko TK, Meric-Bernstam F, Doebele RC, Heymach J, J Clin Oncol, 1/1/2016
Safety, toxicity and activity of multi-kinase inhibitor vandetanib in combination with everolimus in advanced solid tumors.
Cascone R, Hess KR, Piha-Paul SA, Hong DS, Subbiah IM, Bhatt R, Fu S, Naing A, Janku F, Karp DD, Meric-Bernstam F, Heymach J, Subbiah V, J Clin Oncol, 1/1/2016
Impaired cell cycle arrest with concurrent epigenetic deregulation identified through next generation sequencing in patients with advanced carcinoma of unknown primary...
Subbiah IM, Varadhachary G, Tsimberidou AM, Wheler JJ, Subbiah V, Janku F, Roy Chowdhuri S, Zinner R, Hong DS, Cancer Res, 1/1/2015
A phase I study of everolimus (mTOR inhibitor) in combination with vandetanib (multikinase inhibitor of VEGFR, EGFR, and RET) in advanced solid tumors including molecu...
Cascone T, Hess KR, Piha-Paul S, Hong DS, Roxas M, Subbiah IM, Fu S, Naing A, Janku F, Karp D, Sherman SI, Meric-Bernstam F, Heymach JV, Subbiah V, Mol Cancer Ther, 1/1/2015
Concurrent aberrations in the Wnt, MAPK and PI3K pathways identified through next generation sequencing of relapsed refractory colorectal adenocarcinoma (CRC): Implica...
Subbiah IM, Janku F, Tsimberidou AM, Naing A, Subbiah V, Wheler JJ, Zinner R, Eng C, Overman MJ, Kopetz S, Hong DS, Cancer Res, 1/1/2015
Next-generation sequencing of advanced, relapsed colorectal adenocarcinoma (CRC) to reveal mutations affecting Wnt, MAPK and PI3K pathway signaling: Emergence of novel...
Subbiah IM, Janku F, Tsimberidou AM, Naing A, Subbiah V, Wheler JJ, Zinner R, Eng C, Overman MJ, Kopetz S, Palmer GS, Hong DS, J Clin Oncol, 1/1/2015
One size does not fit all: Fingerprinting advanced carcinoma of unknown primary through comprehensive profiling identifies aberrant activation of the PI3K and MAPK sig...
Subbiah IM, Varadhachary G, Palmer G, Tsimberidou AM, Wheler JJ, Subbiah V, Janku F, Chowdhuri SR, Zinner R, Meric-Bernstam F, Hong DS, Cancer Res, 1/1/2014
Next-generation sequencing in carcinoma of unknown primary (CUP) and novel combinatorial strategies in a heterogeneous mutational landscape: Implications for personali...
Subbiah IM, Varadhachary GR, Tsimberidou AM, Wheler JJ, Subbiah V, Falchook GS, Janku F, Zinner R, Roy-Chowdhuri S, Meric-Bernstam F, Hong DS, J Clin Oncol, 1/1/2014
Join now to see all

Lectures

Doing Everything
ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
Rules of Engagement: Regulatory Guidelines when Using Social Media in Healthcare
ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
Managing Cancer Pain through the Integration of Comprehensive Symptom Management.
Houston, TX - 1/27/2018
PROs in Clinical Practice: Utilization of Patient-Reported Outcomes in Routine Symptom Management.
University of Texas MD Anderson Cancer Center, Houston, TX - 1/19/2018
Caring for the whole person: Exploring the continuum between Supportive Care, Palliative Care, & Hospice, Partners in Knowledge
University of Texas MD Anderson Cancer Center, Houston, TX - 1/13/2018
Ethical issues in biomedical sciences in the responsible conduct of research: perspectives from the clinical front lines.
Houston, TX - 1/12/2018
Caring for the whole person: Comprehensive symptom management for patients on immunotherapy-based clinical trials.
Dallas, TX - 1/8/2018
Supportive Care & The Patient Experience: Delivering Patient-Centered Care Through the Integration Of Comprehensive Symptom Management
University of Texas MD Anderson Cancer Center, Houston, TX - 1/1/2018
Supportive Care & the Patient Experience: Comprehensive Care of Persons with Advanced Cancers.
University of Texas MD Anderson Cancer Center, Houston, TX - 1/7/2017
Early Integration of Supportive Care in the Care of Persons with Advanced Cancers.
University of Texas MD Anderson Cancer Center, Houston, TX - 1/3/2017
Join now to see all

Other

Focused Assessment and Study Tool (FAST): Psychiatry and Cognition Module, 3rd Edition
Ishwaria Subbiah, American Academy of Hospice and Palliative Medicine
1/1/2017

Authored Content

Palliative Care in the Time of Hurricane Harvey9/27/2017

Press Mentions

New Oncology Workforce Data Point to Widespread ConcernsOctober 22nd, 2024
Ishwaria Subbiah, MD Joins SCRI as Executive Director for Cancer Care Equity and Professional WellnessMay 15th, 2023
Fatigue Is Common Among Older People. Finding Its Cause Is ImportantMarch 31st, 2023
Join now to see all

Professional Memberships

External Links

MD Anderson Faculty Pagehttp://faculty.mdanderson.org/Ishwaria_Subbiah/Default.asp?SNID=0
LinkedInhttps://www.linkedin.com/in/ishwaria-subbiah-md-ms-8a63637